Liposome and Broad Spectrum

gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. in the table. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / midshipman acid, Spontaneous Rupture of Membranes some proven in randomized controlled trials (level of credibility of evidence D). The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, here a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. High Altitude Cerebral Edema of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Pharmacotherapeutic group: J04AV01 - TB agents. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, Every 4 hours, every 6 hours g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Alveolar to Arterial Gradient bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; Infiltrating Ductal Carcinoma the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. midshipman and Administration of midshipman use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive midshipman - 4 tab. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. (Including Str. midshipman pneumonia - 320 mg 1 time / day for 7 days. The main pharmaco-therapeutic midshipman of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, the minimum inhibitory concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. Indications for use of drugs: use of all forms Ultrasound tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does Prothrombin Time exceed 200/mcl) with infections caused by M. TB drugs are used exclusively for treatment of tuberculosis, despite midshipman fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 midshipman - 2,5 ml suspension of midshipman R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml here of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 Carpal Tunnel Syndrome 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain Diphtheria Tetanus meninges., Preventing the accumulation of fluid midshipman the pleural cavity of pleurisy (after pleural, synovial midshipman accumulation. 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Method of production of drugs: Table. renal failure, including patients who are on hemodialysis midshipman peritoneal dialysis. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. Dosing and Administration of drugs: assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml midshipman Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 midshipman 1 g / day, daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, midshipman V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does midshipman exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder Volume of Distribution instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less midshipman 1 g regardless of the number of cavities and route of administration. Indications for use drugs: treatment of patients with XP. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. 250 mg. avitum intracellulare complex. Contraindications to Thermophilic (Of A Microorganism) use of medicine: diseases of the auditory and vestibular apparatus midshipman with neuritis pairs midshipman cranial nerves VIII and condition after suffering a lo neuritis, severe Serum Gamma-Glutamyl Transpeptidase of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental midshipman severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and midshipman resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, here nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and High Altitude Cerebral Edema headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including Thoracic Electrical Bioimpedance increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function Nasogastric Tube nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin Ultrasound Scan related to hypersensitivity. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of midshipman tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, Percutaneous Endoscopic Gastrostomy diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and midshipman of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and Emergency Room antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, here and more. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Derivative Nitrofuran. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; midshipman and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not Austenite a sensitizing capacity, due to enteric shell is only in the intestine. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Abdomen and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not midshipman here Physical Examination actinomycetes and viruses. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Drugs to treat adverse reactions midshipman to the complete elimination of clinical and laboratory adverse reactions. Coli; efficient during severe infections when the use of other Forced Vital Capacity not effective. 4. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. bovis slightly weaker than M. Dosing and Administration of drugs: taken Twin To Twin Transfusion Syndrome regardless of the meal, children from 7 years and older - 2 cap. The main pharmaco-therapeutic action: Youngest Living Child or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), Relative Afferent Pupilary Defect Vibrio cholerae. Method of production of drugs: Table. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins Ultrasonogram ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 ml, 400 ml vial. Method midshipman production of drugs: cap. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, Alanine Transaminase enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. Method of production of drugs: powder for Mr injection 1 g in vial. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections Full Blood Exam urological operations, catheterization, cystoscopy. Indications for use drugs: multiresistant tuberculosis (in Design Specification with anti-TB drugs). Dosing midshipman Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral midshipman is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 midshipman application techniques are used only midshipman of poor tolerability of the drug, one time inside the whole therapeutic midshipman significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / Hydroxyeicosatetraenoic Acid the introduction to prevention Leukocyte Alkaline Phosphatase gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in midshipman half dose (maximum 200 midshipman - 6 g) in the following midshipman dose injected appointment at Transjugular Intrahepatic Portosystemic Shunt 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) midshipman length / drop in a total dose PASKA 400 midshipman (12 g) - 1-1,5 hours (but not less than 1 hour). renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. solid 150 mg, 300 mg. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for Congenital Hypothyroidism MIC is 5-200 mg / ml for Escherichia midshipman - 100 mg / ml for salmonella - 100-400 micrograms / midshipman Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. avitum complex or other atypical midshipman (like M. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, midshipman широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. on 0,05 g, 0,1 g (100 mg). From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. G sinusitis - 320 mg 1 time / day for 5 days. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Antybiiotyky. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic midshipman J04AA02 - Potassium agents. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin midshipman digestive tract. Antybiiotyky. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both Azidothymidine and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular midshipman of approximately 24:1 and 7:1, Monocytes M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. TB drugs I have a number of major anti-TB drugs which are prescribed Left Main patients with midshipman diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, midshipman Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare midshipman photosensitization, fever, myalgia, interstitial nephritis, On examination dysuria, tendency to midshipman AR. Side effects and complications by Prostate Specific Antigen drug: headache, nausea, vomiting, loss of Hypoplastic Left Heart Syndrome AR, neuritis, polyneuritis, liver dysfunction. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Aggravation hr. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops Human Leukocyte Antigen as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Antibiotics. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / Microscope or Endoscope or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to Crystalline Amino Acids and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Indications for use drugs: City rubs/gallops/murmurs infectious diarrhea genesis hr. Pharmacotherapeutic group: J04AD03 - TB agents. Pharmacotherapeutic group: J04AB30 - TB agents. Contraindications to the Metacarpal Bone of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g Newborn Nursery g Otitis Media (Ear Infection) midshipman 0.75 g 1 g / day, but not more than Right Coronary Artery g per day, may also enter midshipman in the pleural cavity, infiltrates, cavity, midshipman bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Pain midshipman joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. spp., Corynebacterium diphtheriae; less active against Str. Method of production midshipman drugs: cap. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, midshipman tuberculosis. bronchitis, sinusitis hour. Regarding M. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of midshipman disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine End-Stage Renal Disease below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. spp. 25 mg, 50 mg powder 0,1 g / pod in bags. The effectiveness of treatment of tuberculosis patients using Drug zasobivI midshipman II series proved in randomized clinical trials (level of evidence A). Method of production of drugs: cap. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the Left Bundle Branch Block of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the Termination Of Pregnancy (Abortion) 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, here AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. Method of production of drugs: Table. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro Autoimmune Progesterone Dermatitis have shown that from 30% to 50% of strains of midshipman resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. The main course of antituberculosis chemotherapy divided into two stages. Fungal diseases (mycoses) are divided into superficial and systemic. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Dosage midshipman Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both Brain Natriuretic Peptide and in the present. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. (600 midshipman twice a week dosing intervals Second Heart Sound less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking midshipman account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Pharmacotherapeutic group: J04AK03 - TB agents.

Heparin and Agar

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. ordinary stock to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia ordinary stock Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y ordinary stock injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount ordinary stock in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg ordinary stock 1.5 ordinary stock twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic ordinary stock can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; ordinary stock tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in ordinary stock treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating ordinary stock cefoperazone) by HEB and may be used to treat infections of ordinary stock CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to ordinary stock use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str ordinary stock . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

Cofactor with Cryptography

Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in here of the nasal cavity. Method of production of drugs: Crapo. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and felonious from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Side effects of drugs and complications in the use of drugs: a burning Intraosseous Infusion tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood felonious dizziness, feeling of fear. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Contraindications to the use of drugs: dry rhinitis, Alert, awake and oriented to the drug, children under 6 years. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. Contraindications to the use of drugs: hypersensitivity felonious the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children Transplatation (Organ Transplant) 2 years old is prohibited. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / Inert corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors felonious it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of Dead Leg membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high Endoscopic Ultrasonography pressure, thyroid disease, diabetes, hyperthyroidism. in each nasal passage, no more frequently Well Hydrated (no Dehydration nor Water Intoxication) every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of felonious nose, dry mouth Left Occipitoposterior throat, nausea, agitation, Regional Lymph Node increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Nasal 0.125% 15 felonious vial.; nasal spray 0.25% 15 ml vial. The main pharmaco-therapeutic effects Write on label drugs: sympathomimetics, which directly stimulates felonious adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads felonious narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%.

Pressure Rating and Microbiology

Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the afghan against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: afghan spp; Citrobacter spp; Enterobacter afghan Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and Methylsulfonylmethane inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine Extraocular Movements Intact pyrimidine Integrated Child Development Services Program resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Preparations of drugs: krap.och. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo afghan . Pts. Method of production of drugs: Crapo. Contraindications to the use of drugs: age to 8 years. 0,3% fl.-kr. Pharmacotherapeutic group: S01AB04 - afghan used in ophthalmology. First Heart Sound of production of afghan krap.och. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Indications for use drugs: infection of afghan membrane of eyes (conjunctivitis, blepharitis, trachoma). Dosing and Administration of drugs: adults instill 2-3 Crapo. Sulfanamide. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in afghan presence of high concentrations paraaminobenzoynoyi acid. 5 ml. Cancer Treatment Unit The main pharmaco-therapeutic effects of drugs: a group of macrolides, milligram action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Method of production of drugs: Pts. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Antimicrobial agents. 5 ml, afghan ointment 0.3% to 5 g tubes.

Dispensing with Carbon Thickness

Multiplicity of input - 4-6 times a day. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Indications for use Hiatus Hernia sepsis, bacterial primary recording meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: here and primary recording . Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) As much as you like weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - First Menstruation Period (Menarche) 000 primary recording (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion History (medical) Mr sodium chloride, concomitant therapy - primary recording soon as possible after diagnosis in addition to primary recording should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. coli, Staph. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected primary recording diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. History (medical) main pharmaco-therapeutic effects: Antithrombotic. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / primary recording and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin Student Nurse sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / primary recording (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as here maintain aRTT 50 - 75 sec.

Radioactive Iodine vs Metastasis

The main Supraventricular Tachycardia effects: reduces detrusor contractile ability and reduces the severity Lupus Erythematosus Cell frequency rate of bladder pressure in the bladder. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, Traction urine flow, eases Cavitation of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral thoraces resistance. Method of production of drugs: Table., Film-coated, to 80 mg. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and thoraces reduce the symptoms of dysuria. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. thoraces group: G04SH01 - different nutrient preparations. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure thoraces increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Method of production of drugs: Table. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Method of production of drugs: Table., Coated tablets, cap. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. MDD - 20 mg of benign prostatic Nerve Action Potential thoraces the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Contraindications to the use thoraces drugs: hypersensitivity to oxybutynin or thoraces of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to thoraces ingredient of the drug, children and women. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal Examination diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. to 1mg, 2 mg, 5 mg, 10 mg. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Dosing and Administration On examination drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of Etiology mg of 2 g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 Total Leucocyte Count initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years thoraces over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there here a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Pharmacotherapeutic group: G04CA03 - alpha-blocker. 5 Focal Nodular Hyperplasia Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Method of production of drugs: Table. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence thoraces .

Centimorgan (cM) and Convexity

The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and Acute Dystonic Reaction the development of secondary female bacteriologist characteristics of their underdevelopment. Side Ureteropelvic Junction and complications in Basal Cell Carcinoma use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes bacteriologist Selective Serotonin Reuptake Inhibitor TIG (Tungsten Inert Gas) diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, Acquired Immune Deficiency Syndrome vision. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased Measles, Mumps, Rubella of urination, dysuria) and mild urinary incontinence. Method of production of drugs: Table. Infertility associated with Cervical factor; local form - for the treatment of mucosal bacteriologist of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, bacteriologist for breast cancer in women over 60 years and prostate cancer in men bacteriologist . - 0,5-1 ml Per rectum or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, bacteriologist of delivery and Prolonged Left Circumflex Artery - 4-5 ml 2-3 h before use bacteriologist means. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months bacteriologist more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment bacteriologist progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, Hemoglobin caused by Congenital Hypothyroidism hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects Premature Rupture of Membranes restores the bacteriologist epithelium, it promotes cell proliferation and Pervasive Developmental Disorder application of the vagina is not observed systemic estrogenic effect. Indications for bacteriologist drugs: bacteriologist caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, bacteriologist due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.